eli lilly glp 1 Administration Anounces Landmark GLP-1 Pricing Agreement with and Novo Nordisk The FDA has approved a

GLP-1 receptors help regulate insulin secretion, appetite suppression, and glucose balance

They work by mimicking the effects of the naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which is responsible for regulating insulin and blood sugar levels

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

Not tryin to hurt your feelings or anything, but Noom Microdose GLP-1 starts at just $99

President Trump hailed his deal with pharma companies on GLP-1 drug pricing

FDA approval is anticipated in 2026, through the FDA's national priority voucher program, positioning Lilly to compete aggressively in the oral segment